Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025
Absci (Nasdaq: ABSI), a data-first generative AI drug creation company, has scheduled the release of its fourth quarter and full year 2024 financial and operating results. The announcement will be made after market close on March 18, 2025.
The company will host a conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss business developments, financial results, and future outlook. Investors can access the live audio webcast through the company's investor relations website at investors.absci.com. A replay of the webcast will be available after the event.
Absci (Nasdaq: ABSI), un'azienda di creazione di farmaci generativa basata sui dati, ha programmato la pubblicazione dei suoi risultati finanziari e operativi per il quarto trimestre e l'intero anno 2024. L'annuncio sarà fatto dopo la chiusura del mercato il 18 marzo 2025.
L'azienda ospiterà una teleconferenza e un webcast alle 16:30 ora orientale (13:30 ora del Pacifico) per discutere degli sviluppi aziendali, dei risultati finanziari e delle prospettive future. Gli investitori possono accedere al webcast audio in diretta attraverso il sito web delle relazioni con gli investitori dell'azienda all'indirizzo investors.absci.com. Una registrazione del webcast sarà disponibile dopo l'evento.
Absci (Nasdaq: ABSI), una empresa de creación de fármacos generativa basada en datos, ha programado la publicación de sus resultados financieros y operativos del cuarto trimestre y del año completo 2024. El anuncio se realizará después del cierre del mercado el 18 de marzo de 2025.
La empresa llevará a cabo una conferencia telefónica y un webcast a las 4:30 p.m. hora del Este (1:30 p.m. hora del Pacífico) para discutir los desarrollos comerciales, los resultados financieros y las perspectivas futuras. Los inversores pueden acceder al webcast de audio en vivo a través del sitio web de relaciones con inversores de la empresa en investors.absci.com. Una repetición del webcast estará disponible después del evento.
Absci (Nasdaq: ABSI), 데이터 기반 생성 AI 의약품 개발 회사는 2024년 4분기 및 연간 재무 및 운영 결과 발표를 예정하고 있습니다. 발표는 2025년 3월 18일 시장 마감 후 이루어질 것입니다.
회사는 동부 표준시 오후 4시 30분 (태평양 표준시 오후 1시 30분)에 비즈니스 개발, 재무 결과 및 향후 전망에 대해 논의하기 위해 전화 회의 및 웹캐스트를 진행합니다. 투자자들은 회사의 투자자 관계 웹사이트인 investors.absci.com을 통해 실시간 오디오 웹캐스트에 접근할 수 있습니다. 이벤트 후 웹캐스트의 재생이 가능합니다.
Absci (Nasdaq: ABSI), une entreprise de création de médicaments générative axée sur les données, a prévu la publication de ses résultats financiers et opérationnels pour le quatrième trimestre et l'année entière 2024. L'annonce sera faite après la clôture du marché le 18 mars 2025.
L'entreprise organisera une conférence téléphonique et un webcast à 16h30 heure de l'Est (13h30 heure du Pacifique) pour discuter des développements commerciaux, des résultats financiers et des perspectives d'avenir. Les investisseurs peuvent accéder au webcast audio en direct via le site Web des relations avec les investisseurs de l'entreprise à l'adresse investors.absci.com. Un enregistrement du webcast sera disponible après l'événement.
Absci (Nasdaq: ABSI), ein datengestütztes Unternehmen zur generativen Arzneimittelentwicklung, hat die Veröffentlichung seiner finanziellen und operativen Ergebnisse für das vierte Quartal und das gesamte Jahr 2024 geplant. Die Bekanntgabe erfolgt nach Börsenschluss am 18. März 2025.
Das Unternehmen wird um 16:30 Uhr Eastern Time (13:30 Uhr Pacific Time) eine Telefonkonferenz und einen Webcast abhalten, um über Unternehmensentwicklungen, finanzielle Ergebnisse und zukünftige Ausblicke zu diskutieren. Investoren können über die Investor-Relations-Website des Unternehmens unter investors.absci.com auf den Live-Audio-Webcast zugreifen. Eine Wiederholung des Webcasts wird nach der Veranstaltung verfügbar sein.
- None.
- None.
VANCOUVER, Wash. and NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report business updates and financial and operating results for the fourth quarter and full year 2024 after market close on Tuesday, March 18, 2025.
Absci management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss its business developments, financial and operating results, and outlook.
Live audio of the webcast will be available on the company’s investor relations website at: investors.absci.com. The webcast will be archived and available for replay after the event.
About Absci
Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug Creation™ platform unlocks the potential to accelerate time to clinic and increase the probability of success by simultaneously optimizing multiple drug characteristics important to both development and therapeutic benefit. With the data to train, the AI to create, and the wet lab to validate, we can screen billions of cells per week, allowing us to go from AI-designed candidates to wet lab-validated candidates in as little as six weeks. Absci’s headquarters is in Vancouver, WA, with our AI Research Lab in New York City and an Innovation Center in Zug, Switzerland. Visit www.absci.com and follow us on LinkedIn (@absci), X (Twitter) (@Abscibio), and YouTube.
Investor Contact
Alex Khan
VP, Finance & Investor Relations
investors@absci.com
Media Contact
press@absci.com
FAQ
When will Absci (ABSI) release its Q4 and full year 2024 earnings?
What time is Absci's (ABSI) Q4 2024 earnings call?
Where can I listen to Absci's (ABSI) Q4 2024 earnings webcast?
Will Absci's (ABSI) Q4 2024 earnings call be available for replay?
